SPALLONE, VINCENZA
 Distribuzione geografica
Continente #
NA - Nord America 41.190
EU - Europa 5.198
AS - Asia 3.984
SA - Sud America 676
AF - Africa 88
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 17
Totale 51.238
Nazione #
US - Stati Uniti d'America 40.882
IT - Italia 1.917
SG - Singapore 1.663
CN - Cina 729
UA - Ucraina 558
DE - Germania 536
BR - Brasile 496
FR - Francia 418
RU - Federazione Russa 380
IE - Irlanda 352
VN - Vietnam 335
HK - Hong Kong 302
KR - Corea 257
GB - Regno Unito 236
PL - Polonia 174
FI - Finlandia 168
BD - Bangladesh 134
CA - Canada 131
SE - Svezia 128
MX - Messico 127
JP - Giappone 113
NL - Olanda 97
IN - India 87
ES - Italia 76
AU - Australia 69
ID - Indonesia 56
TR - Turchia 51
AR - Argentina 42
CO - Colombia 35
TH - Thailandia 35
ZA - Sudafrica 33
IQ - Iraq 30
PH - Filippine 28
MY - Malesia 27
CL - Cile 26
CH - Svizzera 25
KG - Kirghizistan 24
PE - Perù 24
EC - Ecuador 22
BE - Belgio 20
PK - Pakistan 20
AT - Austria 16
EG - Egitto 16
IR - Iran 16
NZ - Nuova Zelanda 15
UZ - Uzbekistan 15
HU - Ungheria 14
DK - Danimarca 12
EU - Europa 12
RO - Romania 12
CZ - Repubblica Ceca 10
BG - Bulgaria 9
CR - Costa Rica 9
GR - Grecia 9
PY - Paraguay 9
VE - Venezuela 9
MA - Marocco 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 6
IL - Israele 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
LT - Lituania 6
SA - Arabia Saudita 6
UY - Uruguay 6
AZ - Azerbaigian 5
BB - Barbados 5
DZ - Algeria 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
MN - Mongolia 4
NP - Nepal 4
PR - Porto Rico 4
AM - Armenia 3
GE - Georgia 3
MD - Moldavia 3
NI - Nicaragua 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BZ - Belize 2
CG - Congo 2
CM - Camerun 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
ME - Montenegro 2
NG - Nigeria 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 51.222
Città #
Wilmington 11.065
Woodbridge 10.990
Houston 10.005
Singapore 997
Fairfield 804
Chandler 725
Ashburn 611
Ann Arbor 586
San Jose 428
Jacksonville 411
Dublin 330
Beijing 291
Hong Kong 291
Seattle 286
Cambridge 265
Medford 247
Rome 239
Dearborn 215
New York 207
Kraków 153
The Dalles 144
Santa Clara 140
Council Bluffs 136
Los Angeles 125
Lawrence 117
Milan 116
Ho Chi Minh City 110
Redwood City 104
Tokyo 85
Dallas 83
Menlo Park 80
Lauterbourg 78
Hanoi 70
Helsinki 68
Buffalo 66
San Diego 52
Moscow 45
São Paulo 44
Florence 40
Mülheim 38
London 37
Bologna 36
Jakarta 36
Atlanta 35
Naples 35
Boardman 33
Mountain View 33
Toronto 33
Falls Church 32
Phoenix 31
Bangkok 28
Nuremberg 28
Zhengzhou 28
Redondo Beach 27
Orem 26
Palo Alto 26
Chicago 25
Bari 24
Brooklyn 24
Sydney 24
Montreal 23
Palermo 23
University Park 23
Verona 23
Denver 22
Munich 22
Santiago 22
Boston 21
Columbus 21
Da Nang 21
Lima 21
Ankara 20
Dong Ket 20
Guangzhou 20
Newark 20
Barcelona 19
Kansas City 19
Kunming 19
Frankfurt am Main 18
Nanjing 18
Shanghai 18
Detroit 17
Padova 17
Brussels 16
Modena 16
Norwalk 16
Turin 16
Brasília 15
Calgary 15
Mumbai 15
Philadelphia 15
Trieste 15
Warsaw 15
Amsterdam 14
Bogotá 13
Budapest 13
Johannesburg 13
Madrid 13
Melbourne 13
Miami 13
Totale 42.201
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 1.344
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 983
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 964
Neuropatia Diabetica 654
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 573
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 546
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 533
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 529
Il trattamento della psoriasi nell’adulto. Linea guida 25. 528
Neuropatia Diabetica 524
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 518
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 510
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 503
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 501
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 501
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 496
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 489
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 489
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 488
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 484
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 481
Combination Therapy in Diabetic Neuropathy 481
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 478
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 474
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 471
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 471
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 470
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 469
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 468
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 467
Effects of somatostatin on established induced ketosis 466
Diagnosis of cardiovascular autonomic neuropathy in diabetes 466
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 464
Neuropatia e assistenza al diabetico 464
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 463
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 456
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 455
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 454
Benfotiamine: Commentary and update on recent studies 454
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 451
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 449
Autonomic neuropathy: Clinical and instrumental findings 448
Carbohydrate metabolism in hypertension: influence of treatment 448
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 444
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 444
Neuropathy in chronic kidney disease 443
Neuropatia diabetica in Italia 442
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 442
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 441
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 434
The relationship of autonomic neuropathy to other diabetic complications 433
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 433
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 429
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 427
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 427
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 427
Study of conduction velocity in diabetic with autonomic neuropathy. 425
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 425
Methods of investigation for cardiac autonomic dysfunction in human research studies 425
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 425
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 424
Management of painful diabetic neuropathy: guideline guidance or jungle? 423
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 420
Efficacy and safety of lacosamide in painful diabetic neuropathy 419
Might genetics play a role in understanding and treating diabetic polyneuropathy? 419
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 417
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 414
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 413
MicroRNA genetic variations: association with type 2 diabetes 412
Diabetic autonomic neuropathy 411
Painful and painless diabetic neuropathy: one disease or two? 411
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 411
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 406
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 403
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 401
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 400
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 400
Il corretto iter diagnostico della Neuropatia Diabetica 392
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 392
Costruire l'identità del nutrizionista 389
Le nuove frontiere della nutrizione. 388
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 387
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 386
Reply to Circulating erythropoietin in diabetes mellitus. 384
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 384
Time for a Consensus Conference on pain in neurorehabilitation. 380
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 379
Comparative study of periferal and autonomic neuropathy in diabetes 378
Screening e trattamento della neuropatia diabetica 378
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 376
Terapia farmacologica della neuropatia diabetica dolorosa 370
Microvascular complications in children and adolescents with type 1 diabetes 367
Blood Pressure Variability and Autonomic Dysfunction 365
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 364
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 362
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 362
Disfunzione autonomica gastro-enterica e genito-urinaria 360
Impaired alpha cell function in conditions with cortisol deficiency 357
Glycaemic control and gastric emptying 356
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 346
Totale 45.797
Categoria #
all - tutte 104.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/20221.378 48 178 76 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/20241.016 100 54 72 78 105 175 49 69 55 75 69 115
2024/20252.896 135 664 304 202 136 146 257 145 374 211 213 109
2025/20265.482 297 194 516 460 488 200 695 508 617 435 837 235
Totale 51.711